Nurix Therapeutics, Inc.
US ˙ NasdaqGM ˙ US67080M1036

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Christine Ring. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Christine Ring har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:NRIX / Nurix Therapeutics, Inc. Chief Legal Officer 13.579
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Christine Ring. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb NRIX / Nurix Therapeutics, Inc. – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i NRIX / Nurix Therapeutics, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

NRIX / Nurix Therapeutics, Inc. Insider Trades
Insidersalg NRIX / Nurix Therapeutics, Inc. – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i NRIX / Nurix Therapeutics, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2026-04-30 NRIX Ring Christine 3.214 16,6453 3.214 16,6453 53.498 19 15.2400 -4.516 -8,44
2026-01-30 NRIX Ring Christine 4.333 16,5826 4.333 16,5826 71.852
2026-01-30 NRIX Ring Christine 88 17,3717 88 17,3717 1.529
2025-10-30 NRIX Ring Christine 3.644 12,7967 3.644 12,7967 46.631
2025-07-30 NRIX Ring Christine 3.841 12,0110 3.841 12,0110 46.134
2025-04-30 NRIX Ring Christine 2.894 11,5017 2.894 11,5017 33.286
2025-01-30 NRIX Ring Christine 2.929 19,8068 2.929 19,8068 58.014
2025-01-30 NRIX Ring Christine 291 20,3256 291 20,3256 5.915
2024-10-30 NRIX Ring Christine 4.182 24,3050 4.182 24,3050 101.644
2024-07-30 NRIX Ring Christine 2.920 20,6677 2.920 20,6677 60.350
2024-04-30 NRIX Ring Christine 1.513 12,0422 1.513 12,0422 18.220
2024-01-30 NRIX Ring Christine 1.760 7,9902 1.760 7,9902 14.063
2023-10-31 NRIX Ring Christine 1.232 5,1974 1.232 5,1974 6.403
2023-07-31 NRIX Ring Christine 1.420 9,6547 1.420 9,6547 13.710
2023-05-01 NRIX Ring Christine 682 9,8763 682 9,8763 6.736
2023-01-30 NRIX Ring Christine 848 11,7796 848 11,7796 9.989
2022-10-31 NRIX Ring Christine 699 12,8805 699 12,8805 9.003
2022-08-01 NRIX Ring Christine 712 15,6700 712 15,6700 11.157
2022-05-02 NRIX Ring Christine 660 11,7500 660 11,7500 7.755

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

NRIX / Nurix Therapeutics, Inc. Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Christine Ring som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2026-06-02 2026-06-02 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -8.148 13.579 -37,50 16,60 -135.253 225.405
2026-06-02 2026-06-02 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 3.422 21.727 18,69 1,86 6.365 40.412
2026-05-04 2026-05-04 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -8.148 18.305 -30,80 16,96 -138.210 310.497
2026-05-01 2026-05-01 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -5.394 26.453 -16,94 16,76 -90.407 443.368
2026-04-30 2026-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -3.214 31.847 -9,17 16,65 -53.498 530.103
2026-04-30 2026-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2.858 35.061 8,87
2026-04-30 2026-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 3.750 32.203 13,18
2026-04-30 2026-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2.000 28.453 7,56
2026-04-02 2026-04-02 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -8.148 26.453 -23,55 15,24 -124.149 403.056
2026-03-02 2026-03-02 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -8.148 34.601 -19,06 15,44 -125.793 534.188
2026-02-09 2026-02-09 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -14.261 42.749 -25,01 16,66 -237.618 712.288
2026-01-30 2026-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -88 57.010 -0,15 17,37 -1.529 990.361
2026-01-30 2026-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -4.333 57.098 -7,05 16,58 -71.852 946.833
2026-01-30 2026-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2.859 61.431 4,88
2026-01-30 2026-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 3.750 58.572 6,84
2026-01-30 2026-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2.000 54.822 3,79
2026-01-30 2026-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 1.925 52.822 3,78
2026-01-20 2026-01-20 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -3.760 50.897 -6,88 18,42 -69.273 937.711
2026-01-20 2026-01-20 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 3.760 54.657 7,39 1,86 6.994 101.662
2025-12-18 2025-12-18 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -200 50.897 -0,39 18,56 -3.711 944.394
2025-12-18 2025-12-18 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -3.560 51.097 -6,51 17,87 -63.603 912.904
2025-12-18 2025-12-18 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 3.760 54.657 7,39 1,86 6.994 101.662
2025-11-24 2025-11-24 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -37.600 50.897 -42,49 17,07 -641.697 868.629
2025-11-24 2025-11-24 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 37.600 88.497 73,87 1,86 69.936 164.604
2025-10-30 2025-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -3.644 50.897 -6,68 12,80 -46.631 651.314
2025-10-30 2025-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2.858 54.541 5,53
2025-10-30 2025-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 3.750 51.683 7,82
2025-10-30 2025-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2.000 47.933 4,35
2025-10-30 2025-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 1.924 45.933 4,37
2025-07-30 2025-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -3.841 44.009 -8,03 12,01 -46.134 528.592
2025-07-30 2025-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2.858 47.850 6,35
2025-07-30 2025-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 3.750 44.992 9,09
2025-07-30 2025-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2.000 41.242 5,10
2025-07-30 2025-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 1.924 39.242 5,16
2025-04-30 2025-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -2.894 37.318 -7,20 11,50 -33.286 429.220
2025-04-30 2025-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 3.750 40.212 10,28
2025-04-30 2025-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2.000 36.462 5,80
2025-04-30 2025-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 1.924 34.462 5,91
2025-02-03 2025-01-31 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -100 32.538 -0,31 20,48 -2.048 666.378
2025-02-03 2025-01-31 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -5.660 32.638 -14,78 19,94 -112.886 650.949
2025-02-03 2025-01-31 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 5.537 38.298 16,90 1,86 10.299 71.234
2025-02-03 2025-01-31 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 223 32.761 0,69 1,86 415 60.935
2025-01-30 2025-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -291 32.538 -0,89 20,33 -5.915 661.354
2025-01-30 2025-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -2.929 32.829 -8,19 19,81 -58.014 650.237
2025-01-30 2025-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 3.750 35.758 11,72
2025-01-30 2025-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2.000 32.008 6,66
2025-01-30 2025-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 1.924 30.008 6,85
2025-01-02 2025-01-02 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -5.760 28.084 -17,02 19,50 -112.295 547.514
2025-01-02 2025-01-02 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 5.760 33.844 20,51 1,86 10.714 62.950
2024-12-02 2024-12-02 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -5.760 28.084 -17,02 21,73 -125.155 610.218
2024-12-02 2024-12-02 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 5.760 33.844 20,51 1,86 10.714 62.950
2024-11-04 2024-11-04 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -3.290 28.084 -10,49 25,00 -82.250 702.100
2024-11-04 2024-11-04 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 3.290 31.374 11,71 9,57 31.485 300.249
2024-11-01 2024-11-01 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -5.760 28.084 -17,02 24,28 -139.867 681.947
2024-11-01 2024-11-01 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 5.760 33.844 20,51 1,86 10.714 62.950
2024-10-30 2024-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -4.182 28.084 -12,96 24,30 -101.644 682.582
2024-10-30 2024-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 3.750 32.266 13,15
2024-10-30 2024-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2.000 28.516 7,54
2024-10-30 2024-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 1.924 26.516 7,82
2024-10-15 2024-10-14 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -3.290 24.592 -11,80 25,00 -82.250 614.800
2024-10-15 2024-10-14 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 3.290 27.882 13,38 9,57 31.485 266.831
2024-10-01 2024-10-01 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -300 24.592 -1,21 22,81 -6.843 560.944
2024-10-01 2024-10-01 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -5.460 24.892 -17,99 22,19 -121.174 552.431
2024-10-01 2024-10-01 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 5.760 30.352 23,42 1,86 10.714 56.455
2024-09-03 2024-09-03 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -200 24.592 -0,81 25,62 -5.124 630.047
2024-09-03 2024-09-03 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -8.850 24.792 -26,31 24,93 -220.612 618.012
2024-09-03 2024-09-03 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 3.290 33.642 10,84 9,57 31.485 321.954
2024-09-03 2024-09-03 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 5.760 30.352 23,42 1,86 10.714 56.455
2024-08-26 2024-08-26 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -9.870 24.592 -28,64 25,01 -246.843 615.031
2024-08-26 2024-08-26 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 5.407 34.462 18,61 9,57 51.745 329.801
2024-08-26 2024-08-26 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 4.463 29.055 18,15 1,86 8.301 54.042
2024-08-01 2024-08-01 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -300 24.592 -1,21 22,18 -6.655 545.532
2024-08-01 2024-08-01 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -5.460 24.892 -17,99 21,39 -116.804 532.505
2024-08-01 2024-08-01 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 5.760 30.352 23,42 1,86 10.714 56.455
2024-07-30 2024-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -2.920 24.592 -10,61 20,67 -60.350 508.260
2024-07-30 2024-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 3.750 27.512 15,78
2024-07-30 2024-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2.000 23.762 9,19
2024-07-30 2024-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 1.924 21.762 9,70
2024-07-01 2024-07-01 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -801 19.838 -3,88 21,57 -17.277 427.900
2024-07-01 2024-07-01 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -4.959 20.639 -19,37 20,68 -102.560 426.845
2024-07-01 2024-07-01 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 5.760 25.598 29,04 1,86 10.714 47.612
2024-06-13 2024-06-13 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -1.864 19.838 -8,59 17,02 -31.721 337.599
2024-06-13 2024-06-13 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 1.864 21.702 9,40 1,86 3.467 40.366
2024-06-12 2024-06-12 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -1.900 19.838 -8,74 17,01 -32.319 337.444
2024-06-12 2024-06-12 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 1.900 21.738 9,58 1,86 3.534 40.433
2024-06-05 2024-06-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -400 19.838 -1,98 17,00 -6.801 337.296
2024-06-05 2024-06-05 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 400 20.238 2,02 1,86 744 37.643
2024-06-03 2024-06-03 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -1.596 19.838 -7,45 17,01 -27.153 337.506
2024-06-03 2024-06-03 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 1.596 21.434 8,05 1,86 2.969 39.867
2024-04-30 2024-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -1.513 19.838 -7,09 12,04 -18.220 238.893
2024-04-30 2024-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2.000 21.351 10,34
2024-04-30 2024-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 1.924 19.351 11,04
2024-01-30 2024-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -1.760 17.427 -9,17 7,99 -14.063 139.245
2024-01-30 2024-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2.000 19.187 11,64
2024-01-30 2024-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 1.924 17.187 12,61
2023-11-01 2023-10-31 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -1.232 15.263 -7,47 5,20 -6.403 79.328
2023-11-01 2023-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2.000 16.495 13,80
2023-11-01 2023-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 1.924 14.495 15,31
2023-08-01 2023-07-31 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -1.420 12.544 -10,17 9,65 -13.710 121.109
2023-08-01 2023-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 2.000 13.964 16,72
2023-08-01 2023-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 1.924 11.964 19,16
2023-05-02 2023-05-01 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -682 10.040 -6,36 9,88 -6.736 99.158
2023-05-02 2023-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 1.924 10.722 21,87
2023-02-01 2023-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -848 7.261 -10,46 11,78 -9.989 85.532
2023-02-01 2023-01-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 1.924 8.109 31,11
2022-11-01 2022-10-31 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -699 6.185 -10,15 12,88 -9.003 79.666
2022-11-01 2022-10-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 1.924 6.884 38,79
2022-08-02 2022-08-01 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -712 4.615 -13,37 15,67 -11.157 72.317
2022-08-02 2022-07-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 1.924 5.327 56,54
2022-05-03 2022-05-02 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale -660 3.403 -16,24 11,75 -7.755 39.985
2022-05-03 2022-04-30 4 NRIX Nurix Therapeutics, Inc.
Restricted Stock Units
M - Exercise -1.924 28.861 -6,25
2022-05-03 2022-04-30 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise 1.924 4.063 89,95
2022-01-21 2022-01-19 4 NRIX Nurix Therapeutics, Inc.
Restricted Stock Units
A - Award 30.785 30.785
2022-01-21 2022-01-19 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 69.262 69.262
2022-01-11 2022-01-10 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1.200 100.066 -1,18
2022-01-11 2022-01-10 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -1.200 1.286 -48,27 27,14 -32.568 34.902
2022-01-11 2022-01-10 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 1.200 2.486 93,31 1,86 2.232 4.624
2021-12-13 2021-12-10 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1.200 101.266 -1,17
2021-12-13 2021-12-10 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -1.200 1.286 -48,27 29,04 -34.848 37.345
2021-12-13 2021-12-10 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 1.200 2.486 93,31 1,86 2.232 4.624
2021-11-12 2021-11-10 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1.200 102.466 -1,16
2021-11-12 2021-11-10 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -1.200 1.286 -48,27 32,38 -38.856 41.641
2021-11-12 2021-11-10 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 1.200 2.486 93,31 1,86 2.232 4.624
2021-10-28 2021-10-27 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise X -800 103.666 -0,77
2021-10-28 2021-10-27 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -800 1.286 -38,35 35,25 -28.200 45.332
2021-10-28 2021-10-27 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 800 2.086 62,21 1,86 1.488 3.880
2021-10-12 2021-10-11 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1.200 104.466 -1,14
2021-10-12 2021-10-11 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -1.200 1.286 -48,27 27,36 -32.832 35.185
2021-10-12 2021-10-11 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 1.200 2.486 93,31 1,86 2.232 4.624
2021-09-13 2021-09-10 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise X -2.000 105.666 -1,86
2021-09-13 2021-09-10 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -800 1.286 -38,35 36,76 -29.408 47.273
2021-09-13 2021-09-10 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -500 2.086 -19,33 35,77 -17.884 74.613
2021-09-13 2021-09-10 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -700 2.586 -21,30 35,10 -24.568 90.761
2021-09-13 2021-09-10 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 2.000 3.286 155,52 1,86 3.720 6.112
2021-09-08 2021-09-07 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise X -3.200 107.666 -2,89
2021-09-08 2021-09-07 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -3.200 1.286 -71,33 35,25 -112.800 45.332
2021-09-08 2021-09-07 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 3.200 4.486 248,83 1,86 5.952 8.344
2021-08-11 2021-08-10 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1.200 110.866 -1,07
2021-08-11 2021-08-10 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -1.200 805 -59,85 29,87 -35.845 24.046
2021-08-11 2021-08-10 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 1.200 2.005 149,07 1,86 2.232 3.729
2021-07-21 2021-07-20 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1.200 112.066 -1,06
2021-07-21 2021-07-20 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -1.200 805 -59,85 27,00 -32.400 21.735
2021-07-21 2021-07-20 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 1.200 2.005 149,07 1,86 2.232 3.729
2021-06-11 2021-06-10 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1.200 113.266 -1,05
2021-06-11 2021-06-10 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -200 805 -19,90 30,52 -6.103 24.565
2021-06-11 2021-06-10 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -1.000 1.005 -49,88 29,18 -29.179 29.325
2021-06-11 2021-06-10 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 1.200 2.005 149,07 1,86 2.232 3.729
2021-05-11 2021-05-10 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1.200 114.466 -1,04
2021-05-11 2021-05-10 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -1.200 805 -59,85 27,00 -32.400 21.735
2021-05-11 2021-05-10 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 1.200 2.005 149,07 1,86 2.232 3.729
2021-04-29 2021-04-28 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise X -800 115.666 -0,69
2021-04-29 2021-04-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -800 805 -49,84 35,25 -28.200 28.376
2021-04-29 2021-04-28 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 800 1.605 99,38 1,86 1.488 2.985
2021-04-13 2021-04-12 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise X -1.200 116.466 -1,02
2021-04-13 2021-04-12 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -1.200 805 -59,85 27,20 -32.640 21.896
2021-04-13 2021-04-12 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 1.200 2.005 149,07 1,86 2.232 3.729
2021-03-11 2021-03-10 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise X -2.000 117.666 -1,67
2021-03-11 2021-03-10 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -395 805 -32,92 44,11 -17.425 35.511
2021-03-11 2021-03-10 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -405 1.200 -25,23 42,67 -17.280 51.199
2021-03-11 2021-03-10 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -300 1.605 -15,75 41,13 -12.339 66.014
2021-03-11 2021-03-10 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -900 1.905 -32,09 39,44 -35.496 75.133
2021-03-11 2021-03-10 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 2.000 2.805 248,45 1,86 3.720 5.217
2021-02-22 2021-02-18 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
M - Exercise X -2.000 119.666 -1,64
2021-02-22 2021-02-18 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -500 0 -100,00 37,03 -18.516
2021-02-22 2021-02-18 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -1.100 500 -68,75 35,86 -39.444 17.929
2021-02-22 2021-02-18 4 NRIX Nurix Therapeutics, Inc.
Common Stock
S - Sale X -400 1.600 -20,00 34,48 -13.790 55.160
2021-02-22 2021-02-18 4 NRIX Nurix Therapeutics, Inc.
Common Stock
M - Exercise X 2.000 2.000 1,86 3.720 3.720
2021-02-12 2021-02-11 4 NRIX Nurix Therapeutics, Inc.
Employee Stock Option (right to buy)
A - Award 40.000 40.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)